Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, believes in the potential of blood and cells to do even more for patients than they do today. Terumo BCT’s Cell Therapy Technologies business enables researchers, developers and manufacturers to create next-generation cell and gene therapies…[Read more]
Cell and gene therapies are quickly reaching an inflection point, showing great promise for the future of patient care. At GE Healthcare’s Cell Therapy Technologies, we strive to be at the forefront of this revolution by providing the right combination of customized tools, analytics, and support, while helping to standardize and optimize scale-out manufacturing technologies. Together we hope to realize the promise of these revolutionary new medicines and bring them into mainstream clinical use.
Hypertrust Patient Data Care provides next-generation digital health and supply chain solutions leveraging blockchain, AI and IoT. With Hypertrust X-Chain, we deliver a blockchain-based solution securing a patient-centered closed-loop supply and distributed data chain for autologous cell therapies. Hypertrust X- enables a safe, efficient and transparent workflow orchestration across the entire supply chain of autologous cell therapies – with far-reaching benefits for pharma companies and all other stakeholders in the supply and data chain.
Bio-Techne® unites some of the most referenced brands in Life Sciences: R&D Systems®, Novus Biologicals®, Tocris®, ProteinSimple® and Advanced Cell Diagnostics®. Our family of brands collaborate to provide over 50,000 products for Life Science research. We have over 350,000 journal citations, showing that our combined experience is trusted by researchers.
We are passionate about scientific discovery, which drives us to manufacture high-quality reagents and award-winning tools for the Life Science and Clinical Diagnostic markets. We understand our customers and we really care about their research. We want to make sure that their experiments are successful by providing reliable high performance innovative solutions for scientific discovery.
Diamond Pharma Services is a leading European technical and scientific consulting group with deep expertise in advanced therapies. Diamond provided full support to the EU development program and marketing authorisation of YescartaTM, and are the partner of choice for developers of gene, and gene modified cell therapies. Diamond offers a comprehensive service including regulatory affairs, product development (non-clinical, CMC and clinical), pharmacovigilance and quality & compliance.
Data-driven and highly-targeted immunotherapies are the future of the fight against cancer. IsoPlexis, develops novel solutions that are accelerating the revolution in immune and cell-based treatments of cancer. The Isolight, a next-generation analytics platform, profiles responses at the single-cell level enabling researchers to generate a precise functional patient signature to help predict and understand complex response to cancer immunotherapies.
Miltenyi Biotec provides products that advance biomedical research and cellular therapy. Our innovative tools support research from basic research to translational research to clinical application. Our more than 25 years of expertise includes immunology, stem cell biology, neuroscience, and cancer. Miltenyi Biotec has more than 2,500 employees in 28 countries.
Retrogenix provides a fast, accurate and effective solution for primary receptor identification and specificity screening of antibodies, protein ligands, CAR T cells, viruses and small molecules. Physiologically-relevant targets are identified by screening for interactions against the most comprehensive set of plasma membrane proteins available in the context of human cells. This specific sensitive technology is widely used by major global pharmaceutical companies to advance drug discovery and development, predominantly in biologics research.
Werum IT Solutions is the world’s leading supplier of manufacturing execution systems (MES) and manufacturing IT solutions for the pharmaceutical and biopharmaceutical industries. Its PAS-X software product is run by the majority of the world’s top 30 pharmaceutical and biotech companies and by many mid-sized manufacturers…Read More
Recent advances in understanding the genetic basis of diseases are driving major developments in the management of a wide range of disorders. At Seques®, we combine expertise in genomics with extensive experience in healthcare communications. Through partnerships with clients and external experts, we design and create informative, scientifically accurate and impactful programmes for healthcare professionals, patients and other stakeholder groups. Seques® is part of AMICULUM®, an independent global healthcare communications and consultancy business.’